CF Industries Holdings, Inc. (CF)

NYSE · Materials · Agricultural Inputs
By Alex · Tickerpine
$120.01
+2.21 (+1.88%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$18.16B
P/E (TTM)
8.7
Forward P/E
11.3
EPS (TTM)
$13.73
ROE
29.87%
Profit Margin
27.12%
Revenue Growth
17.60%
Dividend Yield
2.04%
Beta
0.40
52W High
$141.96
52W Low
$75.42
Analyst Target
$125.62

CF stock forecast: what analysts expect

Consensus rating
Hold
Avg. 12-month target
$125.62
Implied upside
+4.7%

Wall Street analysts covering CF Industries Holdings, Inc. currently rate the stock a Hold on average, with a mean 12-month price target of $125.62 — +4.7% versus the last price of $120.01. Targets reflect analyst opinion, not a guarantee.

What would an investment in CF be worth today?
Run CF through our free historical return calculator.
Calculate CF returns →

CF historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year +40.7% +40.7% $1,407
3 years +65.9% +18.4% $1,659
5 years +192% +23.9% $2,919
10 years +498% +19.6% $5,984
20 years +5,420% +22.2% $55,205

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in CF.

CF annual returns by year

2026 YTD +56.6%
2025 -7.2%
2024 +10.1%
2023 -4.7%
2022 +22.3%
2021 +87.2%
2020 -15.8%
2019 +12.7%
2018 +5.1%
2017 +40.2%

Congress trading in CF

7 members of Congress have disclosed trading CF — 9 purchases and 4 sales worth an estimated $177,500. Most recent disclosure: Jan 9, 2026.

See who in Congress traded CF →

About CF Industries Holdings, Inc.

CF Industries Holdings, Inc., together with its subsidiaries, engages in the production of ammonia in North America, Europe, and internationally. It operates through Ammonia, Granular Urea, UAN, AN, and Other segments. The company offers ammonia products; nitrogen products, such as granular urea, urea ammonium nitrate solution, and ammonium nitrate; diesel exhaust fluid, urea liquor, and nitric acid products. It serves cooperatives, retailers, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Northbrook, Illinois.

Company website ↗

CF Key Statistics

Previous Close$117.80P/E Ratio8.7
Market Cap$18.16BPEG Ratio2.12
Revenue (TTM)$7.74BROE29.87%
Gross Margin42.49%ROA12.93%
Debt / Equity40.5Employees2,900

CF in plain English

CF stock: frequently asked questions

What is CF Industries Holdings, Inc.'s stock price today?

CF Industries Holdings, Inc. (CF) last traded at $120.01 on the NYSE. Over the past 52 weeks the stock has traded between $75.42 and $141.96.

Is CF stock a buy or a sell?

Wall Street analysts' consensus rating on CF is "Hold", with an average 12-month price target of $125.62 — about +4.7% versus the current price of $120.01. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in CF 10 years ago be worth today?

A $1,000 investment in CF Industries Holdings, Inc. made 10 years ago would be worth about $5,984 today (dividends reinvested) — a total return of 498%, or 19.6% per year.

Does CF pay a dividend?

Yes. CF Industries Holdings, Inc. currently pays a dividend yielding about 2.04% per year at today's share price.

What is CF's P/E ratio?

CF trades at a trailing price-to-earnings ratio of 8.7, and 11.3 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade CF stock?

Yes — 7 members of Congress have disclosed trades in CF under the STOCK Act, totaling 9 purchases and 4 sales worth an estimated $177,500.

What is CF Industries Holdings, Inc.'s ticker symbol?

CF Industries Holdings, Inc. trades under the ticker symbol CF on the NYSE.

Compare CF with peers

CF vs LINLinde plc $479.43 CF vs NEMNewmont Corporation $117.84 CF vs FCXFreeport-McMoRan, Inc. $69.22 CF vs SHWThe Sherwin-Williams Company $360.20 CF vs ECLEcolab Inc. $278.43

Data last refreshed from public sources. Figures may be delayed. Not investment advice.